Moderna Inc (MRNA) — Cash Flow Reinvestment Rate
Moderna Inc (MRNA) has a Cash Flow Reinvestment Rate of 0.05x as of December 2025, reinvesting $48.00 Million (capex $39.00 Million plus investments $-9.00 Million) from operating cash flow of $951.00 Million. Check MRNA cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Moderna Inc Cash Flow Reinvestment Rate (2016–2022)
Historical reinvestment intensity for Moderna Inc across 4 annual periods. Explore Moderna Inc (MRNA) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Moderna Inc (2016–2022)
Year-by-year capital reinvestment analysis for Moderna Inc. For live market cap and broader valuation context, see MRNA market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.12x | $5.58 Billion | $4.98 Billion | $400.00 Million | ▲ +78.9% |
| 2021 | 0.63x | $8.52 Billion | $13.62 Billion | $284.00 Million | ▼ -24.1% |
| 2020 | 0.82x | $1.67 Billion | $2.03 Billion | $67.45 Million | ▼ -91.9% |
| 2016 | 10.22x | $681.75 Million | $66.73 Million | $33.14 Million | — |